Vascular Surgery, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Vascular Surgery, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Ann Vasc Surg. 2021 Feb;71:288-297. doi: 10.1016/j.avsg.2020.07.058. Epub 2020 Sep 2.
The endovascular treatment of peripheral artery obstructive disease in Trans-Atlantic Inter-Society (TASC) C and D lesions involving the aortic bifurcation is a matter of debate. The aim of this study is to evaluate the technical and clinical success of kissing stenting in this context and to analyze predictors of outcome.
All patients treated for aortoiliac TASC C and D lesions with kissing stenting (from 2012 to 2017) in a 6-year period were retrospectively analyzed. Preoperative anatomical features were evaluated by reviewing computed tomography angiography images to identify severe iliac calcifications (SICs) versus not SIC (NSICs). Primary end points were as follows: technical success (TS), procedural success, primary patency (PP), and clinical success (CS). Secondary end points were as follows: secondary patency, assisted patency, survival, mid-term procedure-related complications, and risk factors that affected TS and mid-term results.
In a 6-year period, 51 patients fulfilled the inclusion criteria. TS was achieved in 49 (96.1%) cases. Thirty-one patients (60.8%) received a dual antiplatelet therapy (DAPT) for at least 1 month after the procedure. 30-day CS was 94.1%. Median follow-up was 45.7 months (IQR: 24.5, 8-86 range). The CS was 92.6% at 3 years, with a PP of 86.8% and a secondary patency of 93.2% at 3 years. Six (13.2%) iliac axis occluded during the first follow-up year. NSIC was statistically and independently associated with a lower PP (73% vs. 96%, P = 0.03); DAPT was statistically and independently associated with higher PP than single antiplatelet therapy (96% vs. 75%, P = 0.03); these results were confirmed by Cox regression analysis (HR: 0.14, 95%, IC: 0.01-0.89, P = 0.05 for DAPT analysis; HR: 6.8, 95%, IC: 1.21-59, P = 0.05 for NSIC analysis).
Endovascular treatment for TASC C-D is an effective technique. Postoperative stent occlusion is higher in patients with no DAPT and it usually occurs during the first postoperative year. Preoperative NSIC lesions are associated with reduced PP at 3 years of follow-up.
经跨大西洋腔内治疗学会(TASC)C 和 D 级病变累及主动脉分叉处的外周动脉阻塞性疾病的血管内治疗存在争议。本研究旨在评估该技术治疗吻式支架的技术和临床成功率,并分析其结果的预测因素。
回顾性分析了 6 年内(2012 年至 2017 年)采用吻式支架治疗主髂 TASC C 和 D 病变的所有患者。通过回顾计算机断层血管造影图像来评估术前解剖特征,以确定严重髂动脉钙化(SIC)与非严重髂动脉钙化(NSIC)。主要终点如下:技术成功率(TS)、手术成功率、一期通畅率(PP)和临床成功率(CS)。次要终点包括:二期通畅率、辅助通畅率、生存率、中期与手术相关的并发症以及影响 TS 和中期结果的危险因素。
6 年内,51 名患者符合纳入标准。49 例(96.1%)患者达到 TS。31 名患者(60.8%)术后至少接受了 1 个月的双联抗血小板治疗(DAPT)。30 天 CS 为 94.1%。中位随访时间为 45.7 个月(IQR:24.5,8-86 范围)。3 年 CS 为 92.6%,3 年 PP 为 86.8%,二期通畅率为 93.2%。6 例(13.2%)患者在随访的第一年髂动脉轴闭塞。NSIC 与较低的 PP 呈统计学和独立相关(73%对 96%,P=0.03);与单抗血小板治疗相比,DAPT 与更高的 PP 呈统计学和独立相关(96%对 75%,P=0.03);Cox 回归分析结果也证实了这一点(HR:0.14,95%置信区间:0.01-0.89,P=0.05 用于 DAPT 分析;HR:6.8,95%置信区间:1.21-59,P=0.05 用于 NSIC 分析)。
TASC C-D 的血管内治疗是一种有效的技术。未接受 DAPT 的患者术后支架闭塞率较高,通常发生在术后第一年。术前 NSIC 病变与 3 年随访时的 PP 降低相关。